Who funds antimicrobial resistance research?

We count 236 funded antimicrobial resistance projects, active between 2019 and 2035, from 8 funders. The most came from EU · MSCA (58 projects), Wellcome (54 projects) and EU · ERC (42 projects). The median award is $1.6M, across the 218 of 236 projects that list an amount.

Funded projects

236

Funders

8

Median award

$1.6M

Open calls now

3

Top funders of antimicrobial resistance research

Projects whose title or summary mentions antimicrobial resistance. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.

Open antimicrobial resistance funding calls

3 open calls mention antimicrobial resistance today.

• Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
  National Institutes of HealthNot specifiedDeadline: November 10, 2026 ·
• Project grant for international research collaboration within antimicrobial resistance (EUP OHAMR)
  Swedish Research Council (Vetenskapsrådet)Not specifiedDeadline: February 8, 2027 ·
• NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
  Food and Drug AdministrationUp to $200,000Deadline: April 1, 2027 ·

Forecast: announced, not open yet

1 forecast call on antimicrobial resistance. Funders publish forecasts before a call opens; you can't apply to these yet, and dates can change.

• ForecastDHQP Global NOFO
  Centers for Disease Control - NCEZIDNot specifiedExpected to open March 21, 2027

Funded antimicrobial resistance projects

A sample, latest start first, at most three per program.

• Shared resistance: the hidden contribution of commensals to pathogen antimicrobial resistance
  Wellcome · £1,674,184 · ends 2034
• Decoding inter-species PICI transfer to understand bacterial evolution and design next-generation antibacterial therapies.
  Wellcome · £2,754,059 · ends 2033
• Preventing bacterial disease using the human gut microbiome
  Wellcome · £3,647,306 · ends 2033
• The development, evolution, and dissemination of antimicrobial resistance is one of the greatest threats to the future of human health
  USDA · $980,000 · ends 2031
• De novo molecular design to understand and overcome bacterial pathogens
  UKRI · MRC · £2,186,623 · ends 2031
• Running Rings Round Resistance: Chemical Biology Approaches to Cyclic Antimicrobial Peptide-Lipid Recognition
  UKRI · EPSRC · £2,862,925 · ends 2031
• Understanding the rules of impermeability in Gram negative bacteria
  UKRI · BBSRC · £4,984,228 · ends 2031
• Targeting pathogen respiration as an anti-biofilm strategy
  NIH · NIAID · $3,252,039 · ends 2030
• Altering the infection environment for the eradication of S. aureus infection
  NIH · NIAID · $3,064,333 · ends 2030
• Center for accelerated development of drug candidates targeting high threat bacterial infections
  NIH · NIAID · $7,562,521 · ends 2030

How we count

Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “antimicrobial resistance or antibiotic resistance”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.